Terms of Use

Terms and Conditions Governing the Use of the Agios Website

Introduction

Welcome to the Agios Explore IDH website ('website'). Agios created and maintains this website to provide information to and communicate better with physicians, patients, investors and others who may be interested in learning more about Agios and the products and services it offers. You may use this website, provided you comply with these terms and conditions.

In addition to these terms and conditions, you should also read and be aware of the provisions of our Privacy Policy, which discloses Agios’ practices regarding the collection and use of your personal information, and other policies that govern other parts of our website

Your Acceptance of These Terms and Conditions

Please take a few minutes to carefully review these terms and conditions. By accessing and using this website you agree to follow and be bound by these terms and conditions. If you do not agree to follow and be bound by these terms and conditions, you may not access, use or download materials from this website.

These Terms and Conditions May Change

Agios reserves the right to update or modify these terms and conditions at any time without prior notice. Your use of this website following any such change constitutes your agreement to follow and be bound by the terms and conditions as changed. For this reason, we encourage you to review these terms and conditions every time you use this website.

These terms and conditions were last revised on July 26, 2016.

Keep Me Informed

Receive the latest information about IDH mutations and their role in cancer from Agios.
This information is intended for healthcare professionals.



*Required fields

I would like to receive future communications about IDH mutations from Agios focused on (select one or more):